Gene · 407047
Papers2,619
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,619
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MicroRNA Nobel Prize: Timely Recognition and High Anticipation of Future Products-A Prospective Analysis. | Int J Mol Sci | 2024 | 39684593 | PubTator, text mining | PubMed |
| Retraction: Cancer-associated fibroblasts-derived exosomes suppress immune cell function in breast cancer via the miR-92/PD-L1 pathway. | Front Immunol | 2024 | 39139568 | PubTator, text mining | PubMed |
| A two-miRNA signature (miR-21 and miR-92) in peripheral whole blood as a potential biomarker for diagnosis of human cerebral aneurysms. | Arch Med Sci | 2024 | 39050149 | PubTator, text mining | PubMed |
| Comparison of the diagnostic value of various microRNAs in blood for colorectal cancer: a systematic review and network meta-analysis. | BMC Cancer | 2024 | 38926893 | PubTator, text mining | PubMed |
| Recent Advances in and Application of Fluorescent Microspheres for Multiple Nucleic Acid Detection. | Biosensors (Basel) | 2024 | 38920569 | PubTator, text mining | PubMed |
| Elucidation of how the Mir-23-27-24 cluster regulates development and aging. | Exp Mol Med | 2024 | 38871817 | PubTator, text mining | PubMed |
| Left bundle branch pacing and cardiac remodeling in HF patients with type 2 diabetes mellitus: epigenetic pathways and clinical outcomes. | Front Pharmacol | 2024 | 38835659 | PubTator, text mining | PubMed |
| NANOG controls testicular germ cell tumour stemness through regulation of MIR9-2. | Stem Cell Res Ther | 2024 | 38693576 | PubTator, text mining | PubMed |
| N4-acetylcytidine modifies primary microRNAs for processing in cancer cells. | Cell Mol Life Sci | 2024 | 38308713 | PubTator, text mining | PubMed |
| High-Grade Serous Ovarian Cancer-A Risk Factor Puzzle and Screening Fugitive. | Biomedicines | 2024 | 38275400 | PubTator, text mining | PubMed |
| Potential of Modulating Aldosterone Signaling and Mineralocorticoid Receptor with microRNAs to Attenuate Diabetic Kidney Disease. | Int J Mol Sci | 2024 | 38255942 | PubTator, text mining | PubMed |
| Functionalized Carbon Nanotubes for Delivery of Ferulic Acid and Diosgenin Anticancer Natural Agents. | ACS Appl Bio Mater | 2024 | 38253026 | PubTator, text mining | PubMed |
| Descriptive and Functional Genomics in Neonatal Respiratory Distress Syndrome: From Lung Development to Targeted Therapies. | Int J Mol Sci | 2024 | 38203821 | PubTator, text mining | PubMed |
| Extracellular vesicles released by cancer-associated fibroblast-induced myeloid-derived suppressor cells inhibit T-cell function. | Oncoimmunology | 2024 | 38192443 | PubTator, text mining | PubMed |
| Interplay of miRNAs and lncRNAs in STAT3 signaling pathway in colorectal cancer progression. | Cancer Cell Int | 2024 | 38185635 | PubTator, text mining | PubMed |
| Inhibiting anti-angiogenic VEGF165b activates a miR-17-20a-Calcipressin-3 pathway that revascularizes ischemic muscle in peripheral artery disease. | Commun Med (Lond) | 2024 | 38182796 | PubTator, text mining | PubMed |
| miR-765 as a promising biomarker for low-dose radiation-induced pulmonary fibrosis. | Noncoding RNA Res | 2024 | 38075199 | PubTator, text mining | PubMed |
| Neuronal K+-Cl- cotransporter KCC2 as a promising drug target for epilepsy treatment. | Acta Pharmacol Sin | 2024 | 37704745 | PubTator, text mining | PubMed |
| Extracellular MicroRNAs as Potential Biomarkers for Frail Kidney Phenotype: Progresses and Precautions. | Aging Dis | 2024 | 37611904 | PubTator, text mining | PubMed |
| Insight into Steroid-Induced ONFH: The Molecular Mechanism and Function of Epigenetic Modification in Mesenchymal Stem Cells. | Biomolecules | 2023 | 38275745 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/407047/papers?page=2